Cordycepin, or 3'-deoxyadenosine, is a bioactive compound isolated from fungi of the genus Cordyceps , known for its anticancer, antiviral, and immunomodulatory properties. This molecule, of growing interest in the nutraceutical, cosmetic, and pharmaceutical sectors, also represents a major analytical challenge for laboratories. In this article, we analyze in detail its chemical structure, biological effects, industrial applications, and the regulatory standards governing its use. Emphasis is placed on laboratory assay methods—particularly HPLC and LC-MS/MS —which are essential to guarantee the quality, traceability, and conformity of cordyceps standardized to cordycepin.
Table of Contents
What is cordycepin? Definition, origin, and chemical structure
Definition and chemical designation
Cordycepin, identified by CAS number 73-03-0, is a naturally occurring molecule belonging to the nucleoside analog family. Its full chemical name is 3'-deoxyadenosine , meaning it is a derivative of adenosine lacking the hydroxyl group (–OH) at the 3' position of the ribose. This slight structural modification has major consequences for its biological activity: by substituting for adenosine in certain biochemical processes, cordycepin disrupts RNA synthesis and cell proliferation.
From a physicochemical standpoint, cordycepin is a polar molecule, poorly soluble in common organic solvents but soluble in water, which facilitates certain extraction and quantification methods. Its molar mass is 251.24 g/mol , and its molecular formula is C10H13N5O3 . It is a white or slightly yellowish powder, sensitive to light and heat.
Natural origin: a unique fungal compound
Cordycepin is primarily produced by two species of entomopathogenic fungi: Cordyceps militaris and Cordyceps sinensis . These fungi belong to the Cordycipitaceae family and are well known in traditional Chinese medicine for their revitalizing properties.
The life cycle of Cordyceps sinensis is particularly fascinating. This parasitic fungus develops in the larvae of moths of the genus Thitarodes . Once infected, the larva is gradually colonized by the fungus's mycelium, until it emerges as a small fruiting body (carpophore) protruding from the head of the mummified caterpillar. This wild form is extremely rare and expensive, which explains why Cordyceps militaris , easier to cultivate in the laboratory, is now the main industrial source of cordycepin.
There are also cultivated forms from specific strains such as Paecilomyces hepiali , a mycelial species isolated from C. sinensis , which allows large-scale production while ensuring a chemical composition close to that of the wild mushroom.
Importance of cordycepin in research and industry
Thanks to its structure being similar to adenosine, cordycepin acts as a metabolic decoy, making it a potent inhibitor of RNA transcription . This mechanism gives it a variety of highly sought-after biological properties: inhibition of cell proliferation, activation of the immune response, regulation of inflammatory pathways, and blocking of viral replication.
These properties explain its widespread use in the following sectors:
- Nutraceuticals : health products based on medicinal mushrooms,
- Cosmetics : anti-aging formulas rich in antioxidant compounds,
- pharmaceutical : research on new anticancer or antiviral therapies.
Cordycepin is also used as an analytical marker Cordyceps extracts . Precise quantification of this molecule is essential to guarantee the efficacy of products sold as dietary supplements or for topical use, hence the importance of laboratory analyses, which we will detail in the following sections.
Biological properties and mechanisms of action of cordycepin
Cordycepin has been studied for decades for its remarkable pharmacological effects. Thanks to its unique structure, it interferes with several key cellular processes, giving it antitumor, antiviral, immunomodulatory, anti-inflammatory, and antioxidant properties. These effects have been demonstrated in numerous in vitro and in vivo models and are currently being investigated in clinical trials across several therapeutic areas.
Main mechanism: inhibition of RNA synthesis
The most studied mechanism of action of cordycepin relies on its ability to interfere with RNA synthesis . When phosphorylated in cells to 3'-deoxyadenosine triphosphate (3'-dATP), it can be incorporated in place of adenosine in the forming RNA chain. However, the absence of the hydroxyl group (–OH) at the 3' position prevents normal chain elongation, thus interrupting RNA transcription .
This inhibition of transcription leads to:
- the cessation of cell proliferation,
- the disruption of RNA-dependent metabolic pathways,
- the induction of apoptosis (programmed cell death) in certain cells.
This mechanism is particularly effective against cancer cells or virus-infected cells, which exhibit high transcriptional activity.
Documented anticancer effects
Numerous studies have demonstrated the antitumor of cordycepin on several types of cancer cell lines: leukemia, breast cancer, liver cancer, colon cancer, lung cancer, etc. Among the observed effects:
- inhibition of cell proliferation,
- induction of apoptosis via the mitochondrial pathway,
- reduction in the expression of genes linked to cell survival (Bcl-2, survivin),
- Inhibition of tumor migration and invasion.
A study published in Cancer Letters (2019) for example showed that cordycepin inhibited the growth of liver cancer cells by blocking the activation of the PI3K/Akt pathway, which is essential for cell survival.
The major difficulty lies in its bioavailability: cordycepin is rapidly degraded in the body by adenosine deaminase (ADA). Encapsulated formulations or formulations combined with ADA inhibitors are being studied to improve its in vivo stability.
Antiviral and anti-inflammatory activity
antiviral effects . By disrupting the transcription of viral RNA or inhibiting certain viral RNA polymerases, it limits the replication of single-stranded RNA viruses. Research is underway on its effectiveness against viruses such as the hepatitis B virus, certain coronaviruses, and the herpes virus.
In parallel, cordycepin acts as an inflammation modulator . It inhibits the production of inflammatory mediators such as TNF-α, IL-6, and COX-2, and reduces the expression of transcription factors like NF-κB. This dual effect—antiviral and anti-inflammatory—is particularly beneficial in the context of chronic infection or autoimmunity.
Immunomodulatory properties
Cordycepin stimulates certain responses of the innate and adaptive immune systems :
- macrophage activation,
- increased phagocytosis,
- regulation of cytokine production (IL-2, IFN-γ),
- stimulation of T lymphocytes.
These properties could explain its traditional use as a tonic in Chinese medicine, but they are also of interest to clinical research in the field of anticancer immunotherapy or immunostimulation in immunocompromised individuals.
Antioxidant and neuroprotective activity
Cordycepin is also known for its antioxidant properties , which help neutralize free radicals and reduce cellular oxidative stress. This mechanism helps prevent premature cell aging and protect tissues from oxidative damage.
Some studies also suggest a neuroprotective in cases of cellular stress, neuronal inflammation, or progressive degeneration. These properties are of particular interest to researchers in the fields of preventing cognitive decline or providing support in cases of neurodegenerative diseases.
In summary, cordycepin acts on several biological fronts: RNA transcription, cell signaling, inflammation, immunity, and oxidative stress. This versatility makes it a molecule of priority interest Cordyceps -based products .
Are you looking for an analysis?
Applications of cordycepin in industry
Cordycepin is increasingly attracting the attention of healthcare, cosmetics, and food professionals due to its promising biological effects. Its versatility allows for its incorporation into various finished products, including dietary supplements, cosmetic actives, and drug candidates in development. However, these applications require rigorous control of the quality and concentration of the active ingredient, necessitating precise and standardized laboratory analyses.
Dietary supplements and nutraceuticals
The market for medicinal mushroom-based dietary supplements is booming, with growing demand for natural products with energizing, immune-boosting, or adaptogenic effects. Cordycepin, extracted primarily from Cordyceps militaris , is a key quality marker in these formulations.
Claimed uses
Manufacturers highlight several potential effects:
- boosting energy and reducing fatigue,
- improved vitality and physical recovery,
- immune system support,
- natural antioxidant and anti-aging effect.
These claims, while popular, are not yet validated by the EFSA in Europe. However, Health Canada recognizes the safe use of Cordyceps provided that precise dosages are followed (e.g., 1.5 to 3 g/day of dehydrated powder). Cordycepin, as an active biomarker, plays a crucial role in standardizing extracts.
Available dosage forms
Cordycepin-based products come in several forms:
- raw powder (whole mushroom dehydrated then ground),
- capsules containing powder or standardized extracts,
- liquid extracts (water, alcohol, glycerin),
- CS-4 form : industrially cultivated mycelium from Paecilomyces hepiali , rich in compounds similar to those of Cordyceps sinensis .
The most reliable products are those standardized in cordycepin (≥ 0.03%) and/or cordycepic acid (≥ 7%) , two markers frequently analyzed in the laboratory to guarantee the potency and stability of the extract.
Cosmetic
Cordycepin is incorporated into cosmetic products due to its antioxidant, soothing, and revitalizing properties. This ingredient is valued in skincare products designed to:
- to reduce the signs of aging (wrinkles, loss of elasticity),
- to protect the skin from oxidative stress ,
- to promote cell regeneration .
Examples of applications
Cordycepin can be incorporated into:
- anti-aging serums or moisturizing creams,
- restorative skincare for sensitive skin or skin exposed to pollution,
- formulations targeting skin radiance and regeneration .
The addition of cordycepin to these products must be accompanied by rigorous testing: quantification of the active molecule, stability tests , evaluation of compatibility with other active ingredients, and skin safety tests . Specialized laboratories often perform LC-MS/MS or HPLC analyses to ensure the actual presence of cordycepin in the final formula.
Pharmaceuticals and clinical research
Cordycepin is also being studied for more advanced therapeutic applications, particularly in the fields of oncology, rheumatology, and viral diseases.
Indications explored
Several clinical trials are underway to evaluate:
- The effect of cordycepin as an adjuvant to chemotherapy , to increase the sensitivity of tumor cells,
- its action on osteoarthritis , particularly in slowing down the degradation of articular cartilage ,
- its antiviral potential against RNA viruses, including certain strains of influenza and hepatitis.
This research builds upon previously studied biological mechanisms (inhibition of RNA synthesis, induction of apoptosis, modulation of the immune response). However, the rapid degradation of cordycepin in vivo remains a major obstacle. Solutions are being considered, such as liposomal encapsulation or combination with enzyme inhibitors (ADA inhibitors).
Regulatory framework
In a pharmaceutical context, cordycepin is still considered an active ingredient under development , subject to rigorous evaluations:
- chemical stability
- pharmacokinetic profile,
- safety and efficacy in animal and human models.
Any attempt to register as a pharmaceutical substance requires standardized laboratory analyses , carried out under conditions conforming to ISO 17025 and, if applicable, GMP/GLP (Good Manufacturing or Laboratory Practices) .
Cordycepine and regulations: what the legislation says
Despite its numerous documented biological properties, cordycepin remains a strictly regulated molecule. Depending on its use—dietary supplement, cosmetic ingredient, or pharmaceutical active ingredient—legal requirements vary from country to country. This variability necessitates constant vigilance from manufacturers, as well as rigorous traceability of their cordycepin-containing products.
Regulatory status in Europe
In the European Union, cordycepin is not authorized as an additive or isolated active ingredient in food supplements. However, it may be naturally present in extracts of the mushrooms Cordyceps sinensis or Cordyceps militaris , provided that these extracts come from a safe, documented supply chain that complies with health and safety requirements .
Cordyceps extracts , the European Food Safety Authority (EFSA) requires:
- the full declaration of active ingredients , including cordycepin, adenine and cordycepic acid,
- the assessment of heavy metal levels , particularly lead, arsenic and cadmium,
- toxicity data , particularly in the case of health claims.
Furthermore, the use of Cordyceps militaris or cultivated forms such as Paecilomyces hepiali (strain CS-4) is not authorized in all EU countries. Some Member States classify them as Novel Foods under Regulation (EU) 2015/2283, which requires a prior authorization procedure, including a complete scientific dossier .
Recognition in Canada and the United States
Conversely, in Canada , cordycepin is recognized as an active ingredient in Cordyceps-based natural health products. Health Canada has established specific dosage limits:
- Dehydrated powder : 1.5 to 3 g per day,
- Decoction : up to 9 g/day of dry matter,
- CS-4 form : 1 to 2 g per day.
These thresholds are designed to minimize the risk of side effects while ensuring plausible efficacy. Manufacturers must provide laboratory analyses confirming the presence of the active ingredients (cordycepin, cordycepic acid) and the absence of contaminants.
In the United States , regulations depend on the product's status. If cordycepin is included in a dietary supplement , it falls under the Dietary Supplement Health and Education Act (DSHEA) . However, because it is sometimes extracted from mushrooms classified as "herbs of traditional Chinese medicine," it can also be considered a botanical product , which requires specific regulatory classification, particularly in the case of therapeutic claims.
Cosmetics and external use guidelines
In cosmetic products, cordycepin can be used in the form of a crude mushroom extract , provided that the supplier demonstrates:
- a reliable plant or fungal ,
- the absence of a direct pharmacological effect on the skin,
- results of microbiological and toxicological analyses .
According to Regulation (EC) No 1223/2009 , cosmetic ingredients must be assessed for their safety through a Cosmetic Product Safety Report (CPSR) . This report includes:
- the physico-chemical characterization of the extracts,
- the concentrations of active ingredients (including cordycepin),
- skin or ophthalmological tolerance tests.
No health claims may be made for a cosmetic product containing cordycepin. The terms used must be limited to general cosmetic effects (revitalizing, moisturizing, antioxidant protection, etc.).
The need for rigorous analytical and documentary control
Regulatory compliance necessarily involves the implementation of reliable laboratory analyses , enabling:
- to identify and precisely quantify the cordycepin in the extracts,
- detect the presence of contaminants , including heavy metals, residual solvents, pesticides or microorganisms,
- documenting the botanical or mycological origins of the raw material,
- validate product claims in accordance with local regulations.
These controls are required not only to meet the requirements of regulatory authorities, but also to protect the consumer against falsified or underdosed products, which are common in the market for plant and fungal extracts.
In short, cordycepin can only be used industrially if strict regulatory standards , which vary depending on the region and the intended use. This compliance requires complete traceability , certified laboratory analyses , and constant monitoring of regulatory changes. Any company wishing to market a product containing cordycepin therefore has every interest in collaborating with a laboratory specializing in the analysis of plant and fungal extracts, compliant with ISO 17025 requirements and good analytical practices.
How to analyze cordycepin in the laboratory?
Cordycepin analysis is essential to guarantee the quality, authenticity, and conformity of Cordyceps . Whether for a dietary supplement, a cosmetic product, or a pharmaceutical formulation, precise cordycepin measurement ensures product safety and efficacy. This analysis relies on validated methods, used in laboratories accredited according to ISO 17025 standards, and adapted to complex matrices.
HPLC/UV method: the reference for cordycepin assay
High-performance liquid chromatography (HPLC) coupled with UV detection is currently the reference method for the quantitative analysis of cordycepin in mushroom extracts. This technique relies on separating the constituents of a sample on a chromatographic column, followed by their detection at a specific wavelength.
Advantages of the method:
- High sensitivity : allows detection of cordycepin at very low concentrations (LOQ around 10 mg/kg).
- Good specificity : efficient separation between cordycepin, adenine, adenosine and other components of the mushroom.
- Method validated in numerous laboratories for quality control applications.
The wavelength used for detection is typically 254 nm , which corresponds to the peak absorption of cordycepin. Sample preparation may include water or ethanol extraction, followed by filtration or centrifugation to remove solid particles.
LC-MS/MS mass spectrometry: for complex matrices
In cases where the matrix is particularly complex (plant mixtures, concentrated dry extracts, cosmetic formulations), mass spectrometry coupled with liquid chromatography (LC-MS/MS) is preferred.
This technique offers even higher specificity than HPLC/UV, thanks to the analysis of characteristic ions in cordycepin, which allows:
- detection without interference from other compounds,
- quantification even at trace levels (< 1 mg/kg),
- a multi-residue analysis (possibility of simultaneously measuring several fungal components).
It is recommended in the following contexts:
- Quality control of complex products (multi-ingredient capsules, enriched extracts),
- pharmacokinetic studies,
- investigations in case of complaints or non-conformities.
Other possible techniques: direct UV, NMR, enzymatic titration
Other simpler or more specific techniques can be used depending on the objectives:
- UV/Vis spectrophotometry : used for rapid batch controls, but not very specific.
- Enzymatic titration : in the context of rapid methods in industry (for example to differentiate adenosine from cordycepin in certain extracts).
- Nuclear magnetic resonance (NMR) : a powerful but expensive method, mainly used in research or to validate standards.
Preparation of the samples and matrices concerned
Cordycepin analysis can be performed on various matrices:
- dried mushroom powders (Cordyceps militaris, sinensis),
- or glycerinated extracts
- capsules or tablets,
- cosmetic formulas (creams, serums),
- injectable or experimental solutions in a research context.
The preparation steps include:
- grinding and homogenization of solid samples,
- solvent extraction (water, ethanol, methanol),
- membrane filtration (0.45 µm),
- possibly purification by SPE (solid phase extraction) before injection into chromatography.
Special attention is paid to temperature and light , as cordycepin is sensitive to oxidation and thermal degradation.
Analysis standards and accreditations
For the analysis results to be acceptable to health authorities and industrial clients, they must be carried out according to the following standards:
- ISO 17025 standard : guarantees the competence of testing laboratories,
- COFRAC accreditation (in France) or equivalent depending on the country,
- validation of analytical methods (linearity, precision, specificity, LOD/LOQ, repeatability).
Laboratories must also provide a complete analysis report , stating the method used, the numerical results (in mg/kg or mg/g), the limit of quantification and compliance with product specifications.
Focus on YesWeLab: an analytical partner for your cordyceps extracts
Analyzing cordycepin requires specialized expertise and high-precision laboratory equipment. For nutraceutical, cosmetic, and animal health manufacturers, partnering with a trusted provider is essential to guarantee the quality and compliance of Cordyceps . This is precisely what YesWeLab , a company specializing in multi-sector analytical services, leveraging a network of over 200 accredited partner laboratories across France and Europe.
An expert network dedicated to plant and fungal extracts
YesWeLab collaborates with highly specialized laboratories in the analysis of natural products, in particular:
- standardized extracts of medicinal mushrooms ,
- plant-based raw materials , including bioactive compounds such as cordycepin, cordycepic acid, adenosine, or beta-glucans,
- nutraceutical finished products ( capsules, powders, liquid extracts),
- cosmetic formulations incorporating Cordyceps extracts .
Thanks to this network, YesWeLab is able to offer customized analyses according to the matrices and regulatory requirements of each sector.
Types of matrices analyzed:
- Cordyceps militaris or sinensis powder,
- hydroalcoholic or glycerinated extracts,
- capsules or tablets,
- creams, serums and topical treatments,
- multi-ingredient food supplements.
The results are delivered with a complete analysis report , including the following data:
- cordycepin concentration in mg/kg or as a percentage
- dosage method used,
- limit of detection and quantification (LOD/LOQ),
- compliance with applicable standards (e.g. ISO 17025, COFRAC).
Regulatory support and sector compliance
Beyond analytical services, YesWeLab offers regulatory support on the following issues:
- compliance with European regulations (INCO, Novel Food, EC cosmetics regulation 1223/2009),
- validation of nutritional and health claims,
- preparation of registration or marketing applications,
- adaptation of analytical protocols according to the requirements of EFSA, Health Canada or FDA.
YesWeLab can also advise you on the choice of extract type (CS-4, fruiting body, mycelium), batch standardization, and the selection of reliable suppliers.
A digital platform to simplify the management of analyses
One of YesWeLab's major strengths is its all-in-one digital platform , designed to facilitate the management of your analytical projects:
- Quick search among more than 10,000 available services,
- online ordering of customized analyses,
- real-time monitoring of sample progress,
- secure receipt of results , automatic archiving,
- complete traceability of all operations.
This solution allows companies to centralize all their analytical needs , reduce execution times and optimize the compliance of their products.
Why use YesWeLab for your cordycepin analyses?
ISO 17025 and COFRAC certified laboratories .
✔️ Analysis of cordycepin using validated methods (HPLC, LC-MS/MS).
✔️ Possibility of testing several fungal compounds in a single service.
✔️ Tailor-made regulatory support.
✔️ Easy tracking via an intuitive digital platform.
✔️ Fast turnaround times and guaranteed quality of results.
Cordyceps -based food supplement ? Do you need to validate a standardized cordycepin extract for a cosmetic or pharmaceutical product? YesWeLab is your go-to analytical partner for securing your formulations and ensuring their compliance.
Contact us today for a customized quote or online analysis catalogue
